Antibiotics and Lipid-Modifying Agents: Potential Drug–Drug Interactions and Their Clinical Implications

M Spanakis, D Alon-Ellenbogen, P Ioannou… - Pharmacy, 2023 - mdpi.com
Evidence-based prescribing requires taking into consideration the many aspects of optimal
drug administration (eg, dosage, comorbidities, co-administered drugs, etc.). A key issue is …

[HTML][HTML] Executive summary of the Hellenic Atherosclerosis Society guidelines for the diagnosis and treatment of dyslipidemias-2023

N Katsiki, F Td, C Vlachopoulos, D Panagiotakos… - Atherosclerosis …, 2024 - Elsevier
Atherosclerotic cardiovascular disease (ASCVD) remains the main cause of death
worldwide, and thus its prevention, early diagnosis and treatment is of paramount …

Nutrition, body composition and physical activity have differential impact on the determination of lipidemic blood profiles between young females with different blood …

S Methenitis, SK Papadopoulou, G Panayiotou… - Obesity Research & …, 2023 - Elsevier
Introduction This cross-sectional study explored whether nutrition, body composition, and
physical activity energy expenditure (PAΕΝ) have a differential impact on lipidemic blood …

Obesity and atherosclerotic cardiovascular disease in adults with heterozygous familial hypercholesterolemia: An analysis from HELLAS-FH registry

F Barkas, CV Rizos, G Liamis, I Skoumas… - Journal of Clinical …, 2024 - Elsevier
BACKGROUND Familial hypercholesterolemia (FH) and obesity are well-established risk
factors of atherosclerotic cardiovascular disease (ASCVD). Despite high prevalence, their …

[HTML][HTML] Effects of Chios Mastiha essential oil on cholesterol levels of healthy volunteers: A prospective, randomized, placebo-controlled study (MASTIHA-OIL)

A Kartalis, D Afendoulis, M Didagelos… - Hellenic Journal of …, 2024 - Elsevier
Abstract Introduction Chios Mastiha essential oil (CMO) is a natural product extracted from
the resin of Mastiha, possessing antioxidant, anti-microbial, anti-ulcer, anti-neoplastic, and …

[HTML][HTML] Real-world data on treatment patterns in at least high cardiovascular risk patients on dual and triple lipid lowering therapy in a Hellenic nationwide e …

D Terentes-Printzios, I Dima, P Benardos… - International Journal of …, 2024 - Elsevier
Background Despite recent guidelines appropriate lipid-lowering treatment (LLT) remains
suboptimal in everyday clinical practice. Aims We aimed to describe clinical practice of use …

Risk and mechanism of metabolic syndrome associated with radiation exposure

R Huang, J Miszczyk, PK Zhou - Radiation Medicine and Protection, 2023 - mednexus.org
Obesity, hyperglycemia, hypertension, hypertriglyceridemia and low high-density lipoprotein
cholesterol are the typical features of Metabolic syndrome (MetS). Exploring the risk factors …

Evolocumab use in Greece is associated with early and sustainable reductions in low-density cholesterol (LDL-C) and high persistence to therapy: Results from the …

C Vlachopoulos, D Massia… - Hellenic journal of …, 2023 - pubmed.ncbi.nlm.nih.gov
Evolocumab use in Greece is associated with early and sustainable reductions in low-density
cholesterol (LDL-C) and high persistence to therapy: Results from the Greek cohort analysis of …

[PDF][PDF] Lifelong psychological and lifestyle features in relation to cardiovascular disease development: A narrative review

E Damigou - japt.gr
Despite the extensive literature on individual risk factors, such as diet, physical activity, body
weight, smoking habits, and mental health characteristics, the literature on different lifestyle …